SCHEMBL271797

SCHEMBL271797

CCCCNC1CCCCC1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 2/20 0.52
GNAO1 P09471 2/20 0.52
GNAI1 P63096 2/20 0.52
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
CXCR4 P61073 3/20 0.48
CXCL12 P48061 1/20 0.48
EPHX1 P07099 9/20 0.47
EPHX2 P34913 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
S1PR4 O95977 1/20 0.45
S1PR1 P21453 1/20 0.45
S1PR3 Q99500 1/20 0.45
S1PR5 Q9H228 1/20 0.45
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3687839 1.00 GNAI3 (0.52) GNAI3GNAO1GNAI1MEN1KMT2A
SCHEMBL7775131 1.00 GNAI3 (0.52) GNAI3GNAO1GNAI1MEN1KMT2A
Hydrochloric Acid SCHEMBL9198663 0.98 GNAI3 (0.55) GNAI3GNAO1GNAI1MEN1KMT2A
Water SCHEMBL28273113 0.98 GNAI3 (0.50) GNAI3GNAO1GNAI1MEN1KMT2A
SCHEMBL1485880 0.98 GNAI3 (0.53) GNAI3GNAO1GNAI1MEN1KMT2A
Hydrochloric Acid SCHEMBL7025949 0.95 GNAI3 (0.57) GNAI3GNAO1GNAI1MEN1KMT2A
SCHEMBL24437800 0.93 GNAI3 (0.60) GNAI3GNAO1GNAI1CXCR4CXCL12
SCHEMBL7778149 0.93 GNAI3 (0.60) GNAI3GNAO1GNAI1CXCR4CXCL12
SCHEMBL561543 0.93 GNAI3 (0.60) GNAI3GNAO1GNAI1CXCR4CXCL12
SCHEMBL194145 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 906 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388940-A1 ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS CODEXIS, INC. (US) 2025-12-25 US claimed
EP-4107198-B1 POLYISOCYANATE PREPARATIONS COVESTRO DEUTSCHLAND AG (DE) 2024-03-13 EP claimed
EP-3560975-B2 IONICALLY HYDROPHILIZED POLYISOCYANATES AND ANTIOXIDANTS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-12-06 EP claimed
EP-3724251-B2 IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-11-22 EP claimed
US-20230295673-A1 ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2023-09-21 US claimed
CN-116675858-A Preparation method of amino-terminated hyperbranched polythioether and prepared internal crosslinking modified polyurethane 扬州市祥华新材料科技有限公司 2023-09-01 CN claimed
EP-3851472-B1 IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-06-07 EP claimed
CN-110997832-B Accelerated thermal crosslinking via organic base-added PVDF-HFP and use of crosslinked PVDF-HFP as gate dielectric material for OTFT devices 康宁股份有限公司 2023-05-05 CN claimed
US-11618911-B2 Engineered imine reductases and methods for the reductive amination of ketone and amine compounds CODEXIS, INC. (US) 2023-04-04 US claimed
EP-4107198-A1 POLYISOCYANATE PREPARATIONS Covestro Deutschland AG (DE) 2022-12-28 EP claimed
EP-1082607-A1 SURFACE REGENERATION OF BIOSENSORS Biacore AB (SE) 2001-03-14 EP claimed
WO-1999063333-A1 SURFACE REGENERATION OF BIOSENSORS BIACORE AB (SE) 1999-12-09 WO claimed
US-5602244-A DINUCLEOSIDE PRECURSORS IN OLIGONUCLEOTIDE SYNTHESIS; USEFUL AS ANTISENSE INHIBITORS OF TRANSLATION COMPETITIVE TECHNOLOGIES, INC. (US) 1997-02-11 US claimed
CN-1006805-B METHOD OF REDUCING VISCOSITY IN AQUEOUS COAL SLURRIES BY USE OF PARTIAL ESTERS OF POLYCARBOXYLIC ACIDS HUELS CHEMISCHE WERKE AG (DE) 1990-02-14 CN claimed
EP-0144386-B1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES BECKMAN INSTRUMENTS, INC. (US) 1989-09-06 EP claimed
CN-86106954-A Reduce the method for viscosity in aqueous coal slurries with partial esters of polycarboxylic acids 1987-04-29 CN claimed
EP-0144386-A1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES. BECKMAN INSTRUMENTS INC (US) 1985-06-19 EP claimed
EP-0061746-B1 PHOSPHORAMIDITE COMPOUNDS AND THEIR USE IN PRODUCING OLIGONUCLEOTIDES UNIVERSITY PATENTS, INC. (US) 1985-03-20 EP claimed
WO-1984004749-A1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES BECKMAN INSTRUMENTS INC (US) 1984-12-06 WO claimed
US-4415732-A STORAGE-STABLE NUCLEOSIDES; POLYNUCLEOTIDE SYNTHESIS UNIVERSITY PATENTS, INC. (US) 1983-11-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388940-A1 ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS DCXR, PDXK, XDH GNAI3 3903/4885GNAO1 4078/4885GNAI1 3533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.